Multiple myeloma: Latest News, Top Stories & Analysis

MALVERN, PA — HMP Global is set to host its first Lymphoma, Leukemia & Myeloma (LL&M) Winter Symposium, a pivotal event for healthcare professionals focusing on the latest in hematologic malignancies. …

Regional

FDA Approves DARZALEX FASPRO® for Newly Diagnosed Multiple Myeloma Patients

August 6, 2024August 5, 2024 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration (FDA) recently approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and …